Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Hypertension. 2019 Dec 23;75(2):331–338. doi: 10.1161/HYPERTENSIONAHA.118.12572

Table 2:

Diabetes Incidence rate by Intensive versus Standard blood pressure strategy

Primary and Secondary outcomes Standard Blood
Pressure
N= 4193
Intensive Blood
Pressure
N= 4187
Composite diabetes outcome
 N events 251 299
 Person time years 3217.2 13225.3
 Incidence rate per 1000 person-years of treatment strategy (95% Confidence Intervals) 19.0 (16.8, 21.5) 22.6 (20.2, 25.3)
 Unadjusted Hazard Ratio (95% Confidence Intervals) Reference 1.21 (1.02, 1.44)
 Adjusted Hazard Ratio (95% Confidence Intervals) * Reference 1.17 (0.99, 1.39)
Fasting glucose ≥ 126mg/ dL (≥6.99 mmol/L)
 N events 139 168
 Person time years 13320.2 13235.2
 Incidence rate per 1000 person-years of treatment strategy (95% Confidence Intervals) 10.4 (8.8, 12.3) 12.7 (10.9, 14.7)
 Adjusted Hazard Ratio (95% Confidence Intervals) * Reference 1.19 (0.95, 1.49)
Self-Report of Diabetes
 N events 117 158
 Person time years 13227.2 13252.3
 Incidence rate per 1000 person-years of treatment strategy (95% Confidence Intervals) 8.8 (7.4, 10.6) 11.9 (10.2, 13.9)
 Adjusted Hazard Ratio (95% Confidence Intervals) * Reference 1.34 (1.05, 1.70)
New use of hypoglycemic meds
 N events 94 116
 Person time years 13236.2 13253.2
 Incidence rate per 1000 person-years of treatment strategy (95% Confidence Intervals) 7.1 (5.8, 8.7) 8.8 (7.3, 8.5)
 Adjusted Hazard Ratio (95% Confidence Intervals) * Reference 1.22 (0.92, 1.62)
Secondary Outcome N= 2746 N= 2752
Impaired Fasting glucose: 100- 125 mg/ dL [5.55- 6.94 mmol/L]
 N events 679 793
 Person time years 3013.9 2998.7
 Incidence rate per 100 person-years of treatment strategy (95% Confidence Intervals) 22.5 (21.1, 24.1) 26.4 (24.9, 28.0)
 Adjusted Hazard Ratio (95% Confidence Intervals) Reference 1.17 (1.06, 1.30)
Sensitivity Analysis: Randomized Population N= 4683 N=4678
 N events 251 299
 Person time years 13670 13717
 Incidence rate per 1000 person-years of treatment strategy (95% Confidence Intervals) 18.4 (16.2, 20.8) 21.8 (19.5, 24.4)
 Adjusted Hazard Ratio (95% Confidence Intervals) Reference 1.18 (0.99, 1.40)

Confidence intervals for incidence rates calculated using Wilsons distribution

*

Adjusted model includes age, race, gender, body mass index, antihypertensive medication classes at randomization and estimated glomerular filtration rate. Adjusted model includes 8312 participants (N=68 participants missing baseline estimated glomerular filtration rate or body mass index)

Adjusted model includes 9246 participants (N=115 participants missing estimated glomerular filtration rate or body mass index)